As of 2024-12-15, the Fair Value of Bolt Biotherapeutics Inc (BOLT) is -8.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.53 USD, the upside of Bolt Biotherapeutics Inc is -1,710.80%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -30.49 | -60.73 | -98.59 | -88.10 | -69.20 | -69.42 |
| YoY growth | -163.07% | -99.18% | -62.34% | 10.64% | 21.46% | -58.50% |
| Market Cap (mil) | 20.20 |
| P/E | |
| Forward P/E |
| EPS | -1.70 |
| Avg earnings growth rate | -58.50% |
| TTM earnings | -65.08 |